{"doi":"10.18632/aging.204038","title":"Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties","abstract":"gene which result in constitutive activation of KRas and multiple downstream signaling pathways. It has been difficult to develop specific KRas inhibitors and/or methods that result in recovery of functional TP53 activity. To further elucidate the roles of TP53 in drug-resistance of pancreatic cancer cells, we introduced wild-type (WT) TP53 or a control vector into two different PDAC cell lines. Introduction of WT-TP53 increased the sensitivity of the cells to multiple chemotherapeutic drugs, signal transduction inhibitors, drugs and nutraceuticals and influenced key metabolic properties of the cells. Therefore, TP53 is a key molecule which is critical in drug sensitivity and metabolism of PDAC.","journal":"Aging","year":2022,"id":280374,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9602,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":477166,"name":"Akshaya K. Meher","orcid":"0000-0002-2802-9599","position":1,"is_corresponding":false},{"id":888506,"name":"Shaw M. Akula","orcid":"0000-0001-7990-7307","position":2,"is_corresponding":false},{"id":954808,"name":"Stephen L. Abrams","orcid":"0000-0003-2326-6672","position":3,"is_corresponding":false},{"id":955316,"name":"Linda S. Steelman","orcid":null,"position":4,"is_corresponding":false},{"id":955317,"name":"Michelle M. LaHair","orcid":null,"position":5,"is_corresponding":false},{"id":954809,"name":"Richard A. Franklin","orcid":"0000-0003-0299-9578","position":6,"is_corresponding":false},{"id":954810,"name":"Alberto M. Martelli","orcid":"0000-0001-5196-7260","position":7,"is_corresponding":false},{"id":954811,"name":"Stefano Ratti","orcid":"0000-0002-6258-5345","position":8,"is_corresponding":false},{"id":604667,"name":"Lucio Cocco","orcid":"0000-0002-9206-8277","position":9,"is_corresponding":false},{"id":954812,"name":"Fulvio Barbaro","orcid":"0000-0001-9072-6603","position":10,"is_corresponding":false},{"id":954813,"name":"Przemysław Duda","orcid":"0000-0001-5207-4157","position":11,"is_corresponding":false},{"id":954814,"name":"Agnieszka Gizak","orcid":"0000-0001-9367-0270","position":12,"is_corresponding":false},{"id":954807,"name":"James A. McCubrey","orcid":"0000-0001-6027-3156","position":0,"is_corresponding":true}],"reference_count":103,"raw_metadata":null,"created_at":"2026-07-19T00:29:03.247347Z","pmid":"35477123","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}